PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma

Clinical trial NCT04040491 · UNKNOWN

Trial details

NCT number: NCT04040491
Sponsor: Mingzhi Zhang
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma

Start date: 2019-09-01
Primary completion: 2020-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.